Apogee Therapeutics Inc. (APGE) Ownership

$68.93

$1.34 (-1.91%)
Last update: 03:12 AM EST
Day's range
$67.13
Day's range
$70.25

Apogee Therapeutics Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
BLACKROCK, INC. 02/12/2026 3.78 M $285.62 M   40.88% 6.44%
VANGUARD GROUP INC 01/29/2026 2.86 M $215.71 B   27.26% 4.86%
STATE STREET CORP 02/13/2026 1.69 M $127.58 M   2.09% 2.88%
JPMORGAN CHASE & CO 02/11/2026 1.37 M $103.64 M   20.68% 2.34%
AFFINITY ASSET ADVISORS, LLC 02/13/2026 1.23 M $93.21 M   5.24% 2.10%
GEODE CAPITAL MANAGEMENT, LLC 02/09/2026 1.06 M $79.96 B   18.70% 1.80%
UBS GROUP AG 01/29/2026 974.83 K $73.58 M   21.93% 1.66%
MERCER GLOBAL ADVISORS INC /ADV 02/18/2026 890.67 K $67.23 M   -8.23% 1.52%
MORGAN STANLEY 02/13/2026 890.26 K $67.20 M   91.47% 1.51%
BANK OF AMERICA CORP /DE/ 02/17/2026 793.70 K $59.91 B   101.49% 1.35%
CITADEL ADVISORS LLC 02/17/2026 766.98 K $57.89 B   -34.40% 1.31%
02/12/2026 583.59 K $44.05 M   100.00% 0.99%
JENNISON ASSOCIATES LLC 01/30/2026 578.63 K $43.67 M   100.00% 0.98%
GOLDMAN SACHS GROUP INC 02/10/2026 565.41 K $42.68 B   -5.70% 0.96%
SOFINNOVA INVESTMENTS, INC. 02/13/2026 534.85 K $40.37 M   -5.41% 0.91%
FIRST TURN MANAGEMENT, LLC 02/13/2026 474.84 K $35.84 M   17.88% 0.81%
FRANKLIN RESOURCES INC 02/11/2026 451.00 K $34.04 M   -38.28% 0.77%
EVENTIDE ASSET MANAGEMENT, LLC 02/13/2026 436.02 K $32.91 M   100.00% 0.74%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 02/13/2026 381.36 K $28.79 M   19.21% 0.65%
PICTET ASSET MANAGEMENT HOLDING SA 01/29/2026 312.88 K $23.62 M   100.00% 0.53%
LOOMIS SAYLES & CO L P 02/12/2026 255.44 K $19.28 M   100.00% 0.43%
CANDRIAM S.C.A. 02/13/2026 191.32 K $14.44 M   51.74% 0.33%
MILLENNIUM MANAGEMENT LLC 02/17/2026 140.73 K $10.62 M   -67.31% 0.24%
BARCLAYS PLC 02/13/2026 133.19 K $10.05 M   -79.26% 0.23%
PARKMAN HEALTHCARE PARTNERS LLC 02/17/2026 130.07 K $9.82 M   22.90% 0.22%
TD ASSET MANAGEMENT INC 02/10/2026 129.29 K $9.76 M   55.32% 0.22%
FEDERATED HERMES, INC. 02/12/2026 127.93 K $9.66 M   100.00% 0.22%
UNIVERSAL- BETEILIGUNGS- UND SERVICEGESELLSCHAFT MBH 01/28/2026 127.63 K $9.63 M   -2.90% 0.22%
CAPITAL WORLD INVESTORS 02/11/2026 127.62 K $9.63 M   0.00% 0.22%
KENNEDY CAPITAL MANAGEMENT LLC 02/13/2026 124.98 K $9.43 M   0.75% 0.21%
NUVEEN, LLC 02/12/2026 121.05 K $9.14 M   45.33% 0.21%
BANK OF NEW YORK MELLON CORP 02/10/2026 118.08 K $8.91 M   9.80% 0.20%
NICHOLAS INVESTMENT PARTNERS, LP 02/13/2026 112.92 K $8.52 M   100.00% 0.19%
VICTORY CAPITAL MANAGEMENT INC 02/13/2026 108.27 K $8.17 M   -50.16% 0.18%
TWO SIGMA INVESTMENTS, LP 02/17/2026 105.24 K $7.94 M   -14.00% 0.18%
SCHRODER INVESTMENT MANAGEMENT GROUP 02/13/2026 105.00 K $7.95 M   -51.35% 0.18%
NEUBERGER BERMAN GROUP LLC 02/13/2026 99.65 K $7.52 M   100.00% 0.17%
MANUFACTURERS LIFE INSURANCE COMPANY, THE 02/13/2026 80.83 K $6.12 M   27.85% 0.14%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 02/17/2026 79.40 K $5.99 M   103.59% 0.14%
DEUTSCHE BANK AG\ 02/11/2026 79.36 K $5.99 M   3.68% 0.14%
HUDSON BAY CAPITAL MANAGEMENT LP 02/13/2026 79.00 K $5.96 M   100.00% 0.13%
NOMURA HOLDINGS INC 02/17/2026 76.90 K $5.80 M   100.00% 0.13%
SG AMERICAS SECURITIES, LLC 01/09/2026 73.26 K $5.53 M   -45.42% 0.12%
BOXER CAPITAL MANAGEMENT, LLC 02/17/2026 70.00 K $5.28 M   40.00% 0.12%
PLATINUM INVESTMENT MANAGEMENT LTD 02/13/2026 69.21 K $5.22 M   -26.16% 0.12%
SWISS NATIONAL BANK 02/12/2026 62.90 K $4.75 M   44.93% 0.11%
SIMPLEX TRADING, LLC 02/11/2026 62.80 K $4.74 M   100.00% 0.11%
PRUDENTIAL FINANCIAL INC 02/13/2026 54.30 K $4.10 M   322.24% 0.09%
MARSHALL WACE, LLP 02/13/2026 50.74 K $3.83 M   622.13% 0.09%
SEVEN GRAND MANAGERS, LLC 02/10/2026 50.00 K $3.77 M   100.00% 0.09%

Apogee Therapeutics Inc. institutional Ownership - FAQ's

During the previous two years, 180 institutional investors and hedge funds held shares of Apogee Therapeutics Inc.. The most heavily invested institutionals were:

BlackRock, Inc.: 3.78 M

VANGUARD GROUP INC: 2.86 M

STATE STREET CORP: 1.69 M

JPMORGAN CHASE & CO: 1.37 M

Affinity Asset Advisors, LLC: 1.23 M

GEODE CAPITAL MANAGEMENT, LLC: 1.06 M

116.59% of Apogee Therapeutics Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 27.80 M shares in the last 24 months. This purchase volume represents approximately $1.92 B in transactions.